New anthrahydrazone derivatives and their cisplatin-like complexes: synthesis, antitumor activity and structure–activity relationship
Author:
Affiliation:
1. State Key Laboratory for the Chemistry and Molecular Engineering of Medicinal Resources
2. School of Chemistry & Pharmaceutical Sciences
3. Guangxi Normal University
4. Guilin
5. P. R. China
Abstract
Two new cisplatin-like platinum(ii) complexes of new anthrahydrazones showed significant in vitro antitumor efficacies, which were totally different from that of cisplatin.
Funder
National Natural Science Foundation of China
Natural Science Foundation of Guangxi Province
Guangxi Normal University
Publisher
Royal Society of Chemistry (RSC)
Subject
Materials Chemistry,General Chemistry,Catalysis
Link
http://pubs.rsc.org/en/content/articlepdf/2019/NJ/C9NJ02965F
Reference38 articles.
1. Progress and challenges in the treatment of small cell lung cancer
2. Cancer statistics, 2018
3. Anticancer platinum-based complexes with non-classical structures
4. Platinum Compounds: a New Class of Potent Antitumour Agents
5. The mechanism of tumour cell death by metal-based anticancer drugs is not only a matter of DNA interactions
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Synthesis, crystal structure, DNA binding, and anticancer activity of the cobalt(II), nickel(II), and copper(II) complexes of 9-benzothiazolanthrahydrazone;Journal of Molecular Structure;2024-03
2. From Basics of Coordination Chemistry to Understanding Cisplatin-analogue Pt Drugs;Current Pharmaceutical Design;2023-06
3. Research Progress on the Biological Activities of Metal Complexes Bearing Polycyclic Aromatic Hydrazones;Molecules;2022-12-01
4. (Z)-2-(2-(Anthracen-9-ylmethylene)hydrazineyl)pyrimidine-rhodium(III): Crystal Structure and DNA Binding Property;Crystals;2022-11-18
5. The design and discovery of topoisomerase I inhibitors as anticancer therapies;Expert Opinion on Drug Discovery;2022-03-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3